文献速递重症综合管理与镇静镇痛心脑血管急症

心脏术后延长静脉-动脉体外膜氧合的特征与结局:心脏切开术后体外生命支持(PELS-1)队列研究

Characteristics and Outcomes of Prolonged Venoarterial Extracorporeal Membrane Oxygenation After Cardiac Surgery: The Post-Cardiotomy Extracorporeal Life Support (PELS-1) Cohort Study.
PubMed 文献 · Crit Care Med · 2024-06-07
一句话结论心脏术后ECMO超过7天者近30%,住院死亡率在支持7天后升高(>10天达72.7%),但出院后生存与较短支持时间者无显著差异。

该回顾性观察队列研究纳入2000年至2020年16个国家34个中心共2021例成人心脏术后需ECMO患者,按ECMO持续时间0-3天(n=649,32.1%)、4-7天(n=776,38.3%)、8-10天(n=263,13.0%)和>10天(n=333,16.5%)分组比较特征与结局。主要终点住院死亡率呈U形曲线,4-7天组最低(n=394,50.8%),>10天组最高(n=242,72.7%)。ECMO持续时间较长与出血、急性肾损伤、心律失常和脓毒症等多种并发症相关。各组出院后生存无显著差异;在ECMO>7天亚组中,年龄、合并症、瓣膜疾病和复杂手术与未存活相关。

要点

  • 心脏术后ECMO患者中近30%支持时间>7天(8-10天13.0%,>10天16.5%)。
  • 住院死亡率呈U形曲线:4-7天组最低(n=394,50.8%),>10天组最高(n=242,72.7%)。
  • ECMO持续时间较长与出血、急性肾损伤、心律失常和脓毒症等多种并发症相关。
  • 各ECMO持续时间组出院后生存无显著差异。
  • ECMO>7天患者中,年龄、合并症、瓣膜疾病和复杂手术与未存活相关。

适用人群与场景

  • 2000年至2020年间成人心脏术后需要ECMO支持的患者,来自16个国家34个中心。

研究设计与关键结果

  • 研究类型:回顾性观察队列研究;样本量2021例;34个中心,16个国家;时间2000年1月至2020年12月。
  • ECMO持续时间分组:0-3天 n=649(32.1%),4-7天 n=776(38.3%),8-10天 n=263(13.0%),>10天 n=333(16.5%)。
  • 各ECMO持续时间组间所研究的术前和操作特征无重大差异。
  • ECMO持续时间较长类别与多种并发症相关,包括出血、急性肾损伤、心律失常和脓毒症。
  • 主要终点住院死亡率呈U形曲线:4-7天组最低(n=394,50.8%),>10天组最高(n=242,72.7%)。
  • 各ECMO持续时间组出院后生存无显著差异。
  • ECMO持续时间>7天患者中,年龄、合并症、瓣膜疾病和复杂手术与未存活相关。

证据类型、等级与局限

  • 证据类型:回顾性观察队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 心脏术后ECMO支持超过7天时住院死亡率升高,尤其在瓣膜手术、复杂手术或出现并发症的患者中;但出院后长期预后与较短支持时间者相当。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Most post-cardiotomy (PC) extracorporeal membrane oxygenation (ECMO) runs last less than 7 days. Studies on the outcomes of longer runs have provided conflicting results. This study investigates patient characteristics and short- and long-term outcomes in relation to PC ECMO duration, with a focus on prolonged (> 7 d) ECMO.

DESIGN: Retrospective observational cohort study.

SETTING: Thirty-four centers from 16 countries between January 2000 and December 2020.

PATIENTS: Adults requiring post PC ECMO between 2000 and 2020.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Characteristics, in-hospital, and post-discharge outcomes were compared among patients categorized by ECMO duration. Survivors and nonsurvivors were compared in the subgroup of patients with ECMO duration greater than 7 days. The primary outcome was in-hospital mortality. Two thousand twenty-one patients were included who required PC ECMO for 0-3 days ( n = 649 [32.1%]), 4-7 days ( n = 776 [38.3%]), 8-10 days ( n = 263 [13.0%]), and greater than 10 days ( n = 333 [16.5%]). There were no major differences in the investigated preoperative and procedural characteristics among ECMO duration groups. However, the longer ECMO duration category was associated with multiple complications including bleeding, acute kidney injury, arrhythmias, and sepsis. Hospital mortality followed a U-shape curve, with lowest mortality in patients with ECMO duration of 4-7 days ( n = 394, 50.8%) and highest in patients with greater than 10 days ECMO support ( n = 242, 72.7%). There was no significant difference in post-discharge survival between ECMO duration groups. In patients with ECMO duration greater than 7 days, age, comorbidities, valvular diseases, and complex procedures were associated with nonsurvival.

CONCLUSIONS: Nearly 30% of PC ECMO patients were supported for greater than 7 days. In-hospital mortality increased after 7 days of support, especially in patients undergoing valvular and complex surgery, or who had complications, although the long-term post-discharge prognosis was comparable to PC ECMO patients with shorter support duration.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Bunge JJH, Mariani S, Meuwese C, et al. Characteristics and Outcomes of Prolonged Venoarterial Extracorporeal Membrane Oxygenation After Cardiac Surgery: The Post-Cardiotomy Extracorporeal Life Support (PELS-1) Cohort Study. Crit Care Med. 2024. PMID: 38856631. doi:10.1097/CCM.0000000000006349

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。